What is Emit Imaging?
Emit Imaging operates at the intersection of biotechnology and advanced diagnostics, specializing in Cryo-Fluorescence Tomography (CFT). By providing a sophisticated 3D imaging platform, the company enables researchers to visualize drug distribution and protein expression with unprecedented clarity. Their flagship Xerra platform serves as a cornerstone for automated CFT workflows, significantly reducing the complexity of preclinical studies. With dedicated research facilities in Boston and Baltimore, Emit Imaging provides both high-end instrumentation and specialized fee-for-service research, catering to critical sectors including oncology, gene therapy, and neuroscience. The company's market position is defined by its commitment to high-resolution data acquisition, which is essential for modern drug discovery pipelines.
How much funding has Emit Imaging raised?
Emit Imaging has raised a total of $7.1M across 1 funding round:
Stock/Share Issuance
$7.1M
Stock/Share Issuance (2025): $7.1M, investors not publicly disclosed
Key Investors in Emit Imaging
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Emit Imaging?
Following this major strategic investment, Emit Imaging is poised to expand its footprint within the global life sciences sector. The capital infusion will likely be directed toward enhancing the Xerra platform's capabilities and scaling the company's laboratory services to meet the rising demand for high-fidelity preclinical data. As the firm transitions into a more mature phase of its lifecycle, the focus will shift toward broader commercial adoption and the integration of its imaging technology into larger pharmaceutical research ecosystems. By leveraging its unique CFT methodology, Emit Imaging is set to become an indispensable partner for organizations seeking to streamline their therapeutic development processes and improve the accuracy of biological research outcomes.
See full Emit Imaging company page
